3,000
Participants
Start Date
February 23, 2022
Primary Completion Date
July 31, 2037
Study Completion Date
July 31, 2037
Blood and Urine samples
The samples will be used to identify a range of tests (including genetic, protein and other biomarkers), which along with the clinical data will hopefully identify those most at risk of developing HCC, and to identify HCC at the earliest possible time points.
RECRUITING
Hepatology Clinical Trial Unit, John Radcliffe Hospital, Oxford
Collaborators (2)
Cancer Research UK
OTHER
Roche Diagnostic Ltd.
INDUSTRY
OncImmune Ltd
UNKNOWN
Perspectum
INDUSTRY
University of Nottingham
OTHER
Glasgow Caledonian University
OTHER
University of Oxford
OTHER